Cipla

GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.

GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

Wellthy Therapeutics, established in 2015 and based in Mumbai, India, specializes in digital health solutions. It develops an AI-driven mobile application tailored for type-2 diabetes patients, offering real-time health coaching, personalized education, AI-powered query resolution, and a virtual clinical assistant for doctors. The app also includes features like a lifestyle tracker, interactive lessons, expert coaching, and detailed reports. Wellthy's mission is to bridge global health disparities by delivering scalable, clinically validated digital care solutions that improve patient outcomes and are compliant with regulations.

Cipla Medpro South Africa, a fully-owned subsidiary of Cipla India, is a prominent pharmaceutical company based in Bellville, recognized for producing high-quality medicines at affordable prices. It ranks among the largest pharmaceutical firms in South Africa by volume and is the third largest by value. With a portfolio exceeding 1,000 products across various therapeutic categories, Cipla Medpro employs advanced technology and innovation to address the healthcare needs of patients. The company is committed to agile and sustainable growth, focusing on complex generics and expanding its offerings in digital health and healthcare therapies. Cipla Medpro's dedication to quality and accessibility reflects its legacy as part of a respected global pharmaceutical brand operating in over 100 countries for nearly 80 years.

GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

InvaGen Pharmaceuticals, Inc. is a rapidly growing generic pharmaceutical company based in Hauppauge, New York. The company specializes in the development, manufacturing, marketing, and distribution of high-quality and cost-effective generic prescription medications. InvaGen focuses on a diverse range of therapeutic areas, including cardiovascular, anti-infective, central nervous system disorders, anti-inflammatory, anti-diabetic, and anti-depressant treatments. It offers various dosage forms, including immediate-release and modified-release capsules and tablets, to meet the needs of patients. With operations across multiple facilities in Hauppauge, InvaGen is committed to providing affordable healthcare solutions.

Exelan Pharmaceuticals is a privately held company specializing in the sales and marketing of generic pharmaceuticals, primarily targeting the government and institutional markets. The company partners with a leading global provider of pharmaceutical active ingredients and intermediates, enabling it to offer a diverse range of therapeutic products. Through its strategic alliances and focused approach, Exelan aims to meet the needs of its clients in the pharmaceutical sector.

Quality Chemicals Limited imports and distributes human health, animal health, and environmental and public health products in Uganda.

Chase Pharmaceuticals, established in 2007 and headquartered in Washington D.C., is a specialty pharmaceutical company dedicated to developing treatments for Alzheimer's disease and related neurodegenerative disorders. The company focuses on identifying and clinically developing promising drug candidates, with a particular emphasis on Alzheimer's disease, which currently lacks effective treatments. Chase Pharmaceuticals' lead product, CPC-252, is a transdermal formulation aimed at treating Alzheimer's disease and Parkinsonism dementia. The company operates as a subsidiary of Allergan plc, leveraging its expertise in neuroscience and drug development to advance novel compounds through clinical trials and towards global regulatory approval.

Cipla Medpro South Africa, a fully-owned subsidiary of Cipla India, is a prominent pharmaceutical company based in Bellville, recognized for producing high-quality medicines at affordable prices. It ranks among the largest pharmaceutical firms in South Africa by volume and is the third largest by value. With a portfolio exceeding 1,000 products across various therapeutic categories, Cipla Medpro employs advanced technology and innovation to address the healthcare needs of patients. The company is committed to agile and sustainable growth, focusing on complex generics and expanding its offerings in digital health and healthcare therapies. Cipla Medpro's dedication to quality and accessibility reflects its legacy as part of a respected global pharmaceutical brand operating in over 100 countries for nearly 80 years.

Meditab Specialities Pvt. Ltd. engages in manufacturing and packing of pharmaceutical products such as tablets.